Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Establishment Labs Holdings Inc (ESTA)

Establishment Labs Holdings Inc (ESTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Establishment Labs to Present at Jefferies London Healthcare Conference Business Wire - Fri Nov 7, 7:00AM CST

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 70.71 (+4.35%)
Establishment Labs Reports Third Quarter 2025 Financial Results Business Wire - Wed Nov 5, 7:00AM CST

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 70.71 (+4.35%)
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5 Business Wire - Wed Oct 22, 7:00AM CDT

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 70.71 (+4.35%)
Canaccord Genuity Keeps Their Buy Rating on Establishment Labs Holdings (ESTA) Tipranks - Thu Oct 16, 6:10AM CDT

In a report released yesterday, Caitlin Cronin from Canaccord Genuity reiterated a Buy rating on Establishment Labs Holdings, with a price target of $60.00. The company’s shares closed yesterday at $44.40.Elevate...

ESTA : 70.71 (+4.35%)
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal Business Wire - Tue Oct 14, 7:00AM CDT

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the...

ESTA : 70.71 (+4.35%)
Establishment Labs Publishes 15 Years of Motiva Data in 2025 Post-Market Surveillance Report Business Wire - Thu Oct 9, 7:00AM CDT

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced...

ESTA : 70.71 (+4.35%)
Citi Sticks to Its Hold Rating for Establishment Labs Holdings (ESTA) Tipranks - Wed Oct 8, 6:40AM CDT

In a report released on October 3, Joanne Wuensch from Citi maintained a Hold rating on Establishment Labs Holdings, with a price target of $43.00. The company’s shares closed yesterday at $39.33.Elevate...

ESTA : 70.71 (+4.35%)
Mizuho Securities Remains a Buy on Establishment Labs Holdings (ESTA) Tipranks - Tue Oct 7, 7:44AM CDT

Mizuho Securities analyst Anthony Petrone reiterated a Buy rating on Establishment Labs Holdings today and set a price target of $70.00. The company’s shares closed last Friday at $41.43.Elevate Your...

ESTA : 70.71 (+4.35%)
Establishment Labs Amends Credit Agreement with Oaktree Tipranks - Sat Oct 4, 6:22AM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Establishment...

ESTA : 70.71 (+4.35%)
Establishment Labs Reports Second Quarter 2025 Financial Results Business Wire - Thu Aug 7, 7:00AM CDT

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 70.71 (+4.35%)

Barchart Exclusives

Is This Dividend Stock a Buy for 2026 After Rising 265% in 2025? Barchart - Thu Dec 4, 6:30PM CST
Anglogold Ashanti shares have soared this year amid a spike in gold prices. While the shares might take a breather for now, it is a buy-on-the-dip candidate for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot